Subtype
Ovarian Neoplasm
CI-CAN-00001335Explore in graph →
Non-malignant747 active trials5 approved drugs94 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001335Explore in graph →
Clinical trials
3,431 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05931445 | Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer | active not recruiting | N/A | 500 | Comprehensive Support Project for Oncology ResearchOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06379191 | The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program | completed | N/A | 78 | Peking Union Medical College HospitalOTHER | 1 | Apr 23, 2024 |
| clinicaltrials |
| NCT06376604 | Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies | unknown | N/A | 30 | L-Nutra IncINDUSTRY | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04731441 | Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact | terminated | N/A | 12 | Milton S. Hershey Medical CenterOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT04898842 | Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet(BOUNCED) | completed | N/A | 30 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT04298827 | Gyn Onc Prehab Study | completed | N/A | 83 | St. Louis UniversityOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT06328491 | Erdafitinib in Metastatic Steroid-cell Ovarian Cancer | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT05305820 | Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy(PANO) | unknown | N/A | 36 | Dublin City UniversityOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06277947 | Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward(GARD-HIPEC) | unknown | N/A | 92 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04145388 | Family History Study on Cancer Risk | unknown | N/A | 18,623 | Kaiser PermanenteOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT06254781 | Luspatercept in Metastatic AGCT of the Ovary | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT06250686 | Exercise and Nutrition Intervention in Ovarian Cancer(BENITA) | unknown | N/A | 185 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT05529303 | Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients | completed | N/A | 80 | Kevser PamukOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT01350908 | Study of Circulating Tumoral DNA in Ovarian Cancer | completed | N/A | 25 | Institut CurieOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05490407 | Role of the ATP7A Transporter in Ovarian Cancer(ATHOC) | completed | N/A | 40 | University Medical Centre LjubljanaOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT06232122 | Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer | recruiting | N/A | 45 | Chang Gung Memorial HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT04066361 | OPTimizing Treatment Focused Genetic Testing IN Cancer(OPT-IN) | completed | N/A | 301 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT04330716 | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers(GeneBOPP) | completed | N/A | 269 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT03606486 | Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer | terminated | N/A | 52 | University of WashingtonOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT03641287 | The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors | terminated | N/A | 64 | University of WashingtonOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT03412630 | Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab | terminated | N/A | 1 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Nov 24, 2023 | clinicaltrials |
| NCT05444270 | Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer(SABR-ROC) | recruiting | N/A | 270 | Yonsei UniversityOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT06145295 | The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life | completed | N/A | 68 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT05048407 | Sirius in Gynaecological Laparoscopic Surgery | unknown | N/A | 30 | Precision Robotics (Hong Kong) LimitedINDUSTRY | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05960630 | MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer(MIRRORS-RCTP) | unknown | N/A | 20 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06103214 | The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery | completed | N/A | 144 | Zhejiang Cancer HospitalOTHER | 0 | Oct 26, 2023 | clinicaltrials |
| NCT02477202 | Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation | completed | N/A | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT03364673 | Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer | completed | N/A | 29 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT01683877 | Efficacy Study of FloSeal in Hemostasis After Laparoscopic Ovarian Cystectomy | completed | N/A | 128 | Asan Medical CenterOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT05025748 | Ask Questions (ASQ):Implementation of a Communication Intervention | completed | N/A | 81 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT00968799 | Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study | terminated | N/A | 6 | Cantonal Hospital of St. GallenOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05318625 | A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. | unknown | N/A | 30 | Precision Robotics (Hong Kong) LimitedINDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05372692 | Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer | completed | N/A | 3 | Weijia Fang, MDOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT03339765 | Self-Advocacy Serious Game in Advanced Cancer | completed | N/A | 78 | University of PittsburghOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT05833321 | Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer(SARCO-GYN) | recruiting | N/A | 75 | Centre Hospitalier Metropole SavoieOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT03563781 | SEntine Lymph Node in earLY Ovarian Cancer (SELLY)(SELLY) | completed | N/A | 176 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT04902144 | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | completed | N/A | 6 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT05862740 | ULTRA-LAP Trial: Laparoscopic Debulking Surgery (LDS) in Advanced Ovarian Cancer(ULTRA-LAP) | recruiting | N/A | 62 | Azienda Ospedaliera di PadovaOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05749211 | Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer | unknown | N/A | 59 | Ruijin HospitalOTHER | 0 | May 16, 2023 | clinicaltrials |
| NCT05813509 | Individualized Precision Treatment Based on Ovarian Cancer Organoid Model | unknown | N/A | 30 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT05810701 | FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer(FRAGINOC) | recruiting | N/A | 300 | Odense University HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05776355 | NKG2D CAR-NK & Ovarian Cancer | unknown | N/A | 18 | Hangzhou Cheetah Cell Therapeutics Co., LtdOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05769205 | MRI in Ovarian Tumors | unknown | N/A | 25 | Assiut UniversityOTHER | 0 | Mar 15, 2023 | clinicaltrials |
| NCT05184140 | Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer(MELISA) | unknown | N/A | 62 | Hospital Clinic of BarcelonaOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT02227654 | Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors | completed | N/A | 179 | Frederick R. Ueland, M.D.OTHER | 1 | Mar 2, 2023 | clinicaltrials |
| NCT04438564 | Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients | unknown | N/A | 300 | China Medical University HospitalOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT02595281 | HE4 as a Relapse Biomarker in Ovarian Cancers(PRONOV4IR) | completed | N/A | 90 | Institut de Cancérologie de LorraineOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT03162289 | Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers(FIT2) | unknown | N/A | 150 | Charite University, Berlin, GermanyOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT01272817 | Nonmyeloablative Allogeneic Transplant(Mini-allo) | completed | N/A | 36 | Scripps HealthOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT05607329 | Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial | recruiting | N/A | 400 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Nov 7, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Apr 23, 2024source: clinicaltrials